Emmanuel Seront

Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects

Elisa Boscolo, Nisha Limaye, Lan Huang et al. · Journal of Clinical Investigation · 2015 · 240 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study

Jennifer Hammer, Emmanuel Seront, Steven Duez et al. · Orphanet Journal of Rare Diseases · 2018 · 235 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Genetic Basis and Therapies for Vascular Anomalies

Angela Queisser, Emmanuel Seront, Laurence M. Boon et al. · Circulation Research · 2021 · 230 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Emmanuel Seront, Sylvie Rottey, Brieuc Sautois et al. · Annals of Oncology · 2012 · 124 citations · Full text

Medicine, Oncology, Pharmacology +14

Antitumor Activity of 7-Aminocarboxycoumarin Derivatives, a New Class of Potent Inhibitors of Lactate Influx but Not Efflux

Nihed Draoui, Olivier Schicke, Emmanuel Seront et al. · Molecular Cancer Therapeutics · 2014 · 120 citations · Full text

Medicine, Oncology, Pharmacology +15